Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) · Nasopharyngeal Carcinoma · Lymphoepithelial Carcinoma · Rhabdomyosarcoma · Neuroblastoma · Medulloblastoma · Wilms Tumor · Atypical Teratoid/Rhabdoid Tumors · Diffuse Intrinsic Pontine Gliomas · Other EGFR-positive Pediatric Solid Tumors Deemed Eligible by the Investigator
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Principal Investigator (Yizhuo Zhang)